281 related articles for article (PubMed ID: 28701516)
1. Blocking TGF-
Nlandu-Khodo S; Neelisetty S; Phillips M; Manolopoulou M; Bhave G; May L; Clark PE; Yang H; Fogo AB; Harris RC; Taketo MM; Lee E; Gewin LS
J Am Soc Nephrol; 2017 Dec; 28(12):3490-3503. PubMed ID: 28701516
[TBL] [Abstract][Full Text] [Related]
2. Deleting the TGF-β receptor attenuates acute proximal tubule injury.
Gewin L; Vadivelu S; Neelisetty S; Srichai MB; Paueksakon P; Pozzi A; Harris RC; Zent R
J Am Soc Nephrol; 2012 Dec; 23(12):2001-11. PubMed ID: 23160515
[TBL] [Abstract][Full Text] [Related]
3. Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-catenin.
Zhang M; Lee CH; Luo DD; Krupa A; Fraser D; Phillips A
J Biol Chem; 2007 Sep; 282(39):28639-28647. PubMed ID: 17623674
[TBL] [Abstract][Full Text] [Related]
4. Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease.
Nlandu-Khodo S; Osaki Y; Scarfe L; Yang H; Phillips-Mignemi M; Tonello J; Saito-Diaz K; Neelisetty S; Ivanova A; Huffstater T; McMahon R; Taketo MM; deCaestecker M; Kasinath B; Harris RC; Lee E; Gewin LS
JCI Insight; 2020 May; 5(10):. PubMed ID: 32369448
[TBL] [Abstract][Full Text] [Related]
5. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
6. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
[TBL] [Abstract][Full Text] [Related]
7. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
8. Augmenter of liver regeneration inhibits TGF-β1-induced renal tubular epithelial-to-mesenchymal transition via suppressing TβR II expression in vitro.
Liao XH; Zhang L; Chen GT; Yan RY; Sun H; Guo H; Liu Q
Exp Cell Res; 2014 Oct; 327(2):287-96. PubMed ID: 25092350
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
10. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX
Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960
[TBL] [Abstract][Full Text] [Related]
11. Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis.
Ho C; Lee PH; Hsu YC; Wang FS; Huang YT; Lin CL
Am J Med Sci; 2012 Nov; 344(5):374-82. PubMed ID: 22270399
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway.
Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X
PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502
[TBL] [Abstract][Full Text] [Related]
13. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
14. Deleting the TGF-β receptor in proximal tubules impairs HGF signaling.
Nlandu Khodo S; Neelisetty S; Woodbury L; Green E; Harris RC; Zent R; Gewin L
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F499-510. PubMed ID: 26739889
[TBL] [Abstract][Full Text] [Related]
15. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
16. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.
Wolf G; Schroeder R; Ziyadeh FN; Stahl RA
Kidney Int; 2004 Nov; 66(5):1849-58. PubMed ID: 15496155
[TBL] [Abstract][Full Text] [Related]
17. Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
Neelisetty S; Alford C; Reynolds K; Woodbury L; Nlandu-Khodo S; Yang H; Fogo AB; Hao CM; Harris RC; Zent R; Gewin L
Kidney Int; 2015 Sep; 88(3):503-14. PubMed ID: 25760325
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
[TBL] [Abstract][Full Text] [Related]
19. Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.
Zhou L; Li Y; Zhou D; Tan RJ; Liu Y
J Am Soc Nephrol; 2013 Apr; 24(5):771-85. PubMed ID: 23559584
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
